Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 605 participants.
Also called NCT04035824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 605 participants
- Sponsor
- Registry
-
NCT04035824
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04035824. Randomized; double masking; primary purpose treatment. Start 2019-10-08 (actual); primary completion 2024-04-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
- Condition
- Hypertension
- Intervention (Drug)
- Gastrodia and Uncaria granule
- Intervention (Drug)
- Placebo of Gastrodia and Uncaria granule
- Lead sponsor
- Shanghai Institute of Hypertension
- Collaborator
- Ruijin Hospital
- Collaborator
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct04035824- Content hash
59ea662f94a3c31f3637d6a07d37c9c80250ea959033360467b128bdade649a1